Bay City Capital Management IV LLC's Net Worth
$128 Million
Who is Bay City Capital Management IV LLC?
Bay City Capital Management IV LLC has an estimated net worth of $128 Million. This is based on reported shares across multiple companies, which include EnteroMedics Inc, MADRIGAL PHARMACEUTICALS, INC., NEVRO CORP, PONIARD PHARMACEUTICALS, INC., and VIA Pharmaceuticals, Inc..
SEC CIK
Bay City Capital Management IV LLC's CIK is 0001359070
Past Insider Trading and Trends
2007 was Bay City Capital Management IV LLC's most active year for acquiring shares with 62 total transactions. Bay City Capital Management IV LLC's most active month to acquire stocks was the month of July. 2020 was Bay City Capital Management IV LLC's most active year for disposing of shares, totalling 10 transactions. Bay City Capital Management IV LLC's most active month to dispose stocks was the month of October. 2009 saw Bay City Capital Management IV LLC paying a total of $14,391,939.82 for 105,740,388 shares, this is the most they've acquired in one year. In 2019 Bay City Capital Management IV LLC cashed out on 1,200,000 shares for a total of $126,564,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EnteroMedics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.67% | 840K |
$1.65 | $1,386,000.00 | 4.9M |
Sep 23
| |||
Form 4
| +104.70% | 3.33M |
$1.74 | $2,958,000.00 | 6.5M |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
| +59.31% | 1.65M |
$1.15 | $1,896,907.75 | 4.43M |
Feb 19
| |||
Form 4
| +1.82% | 49.6K |
$1.10 | $54,560.00 | 2.78M |
Oct 24
| |||
Form 4
| +0.92% | 25K |
$4.50 | $112,500.00 | 2.73M |
Apr 29
| |||
Form 4
| +1.88% | 50K |
$4.50 | $225,000.00 | 2.71M |
Apr 24
| |||
Form 4
| +0.80% | 21K |
$8.66 | $181,860.00 | 2.66M |
Feb 29
| |||
Form 4
| +602.80% | 2.26M |
—
|
—
| 2.64M |
Nov 20
| |||
Form 4
|
∞
| 375K |
$8.00 | $3,000,000.00 | 375K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $187.995
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -35.28% | -824.17K |
—
|
—
| 1.51M |
Dec 3
| |||
Form 4
| -1.85% | -43.54K |
—
|
—
| 2.31M |
Dec 1
| |||
Form 4
| -39.63% | -1.55M |
—
|
—
| 2.35M |
Sep 4
| |||
Form 4
| -41.17% | -30.00K |
$109.74 | -$3,292,195.83 | 42.88K |
Aug 17 - Aug 19
| |||
Form 4
| -9.60% | -412.24K |
—
|
—
| 3.88M |
May 27
| |||
Form 4
| -22.31% | -1.20M |
$105.47 | -$126,564,000.00 | 4.18M |
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEVRO CORP (NVRO) Snapshot price: $17.055
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.18% | -491.83K |
$47.94 | -$23,578,569.90 | 1.73M |
Jun 8
| |||
Form 4
| +9,154.97% | 2.19M |
—
|
—
| 2.22M |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PONIARD PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.44% | 74.97K |
$5.80 | $442,223.16 | 16.93M |
Aug 30
| |||
Form 4
| +0.09% | 4.94K |
$5.75 | $28,381.15 | 5.57M |
Aug 29
| |||
Form 4
| +0.05% | 5.17K |
$5.49 | $28,338.72 | 11.12M |
Aug 14 - Aug 16
| |||
Form 4
| +0.25% | 13.63K |
$5.50 | $74,976.00 | 5.56M |
Aug 10
| |||
Form 4
| +23.18% | 1.04M |
$6.33 | $6,605,456.28 | 5.55M |
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VIA Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +48.44% | 4.07M |
$2.43 | $9,880,336.26 | 12.46M |
Aug 8
| |||
Form 4
|
∞
| 8.39M |
—
|
—
| 8.39M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||